APO RESEARCH · REPORT
Docetaxel
Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.
Product & engineering
Understand the product.
Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.
Selected research
Industry Research
Docetaxel Industry Research Report 2026
Market perspective
Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.
China Docetaxel key players include Hengrui Medicine, Sanofi, Qilu Pharma, Shenzhen Main Luck Pharma, etc. Top four companies hold a share over 80%. In terms of product, 20 mg/ml is the largest segment, with a share nearly 85%.
Report Scope
Read the full market overview
This report quantifies the global Docetaxel market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Docetaxel Market by Company
Hengrui Medicine
Sanofi
Qilu Pharma
Shenzhen Main Luck Pharma
Jiangsu Aosaikang Pharma
Docetaxel Segment by Type
20 mg/ml
40 mg/ml
60 mg/ml
Docetaxel Segment by Application
Breast Cancer
Prostate Cancer
Non-small Cell Lung Cancer
Others
Docetaxel Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Docetaxel market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Docetaxel and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Docetaxel.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Docetaxel manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Docetaxel by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Docetaxel in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 20 mg/ml
- 40 mg/ml
- 60 mg/ml
Applications
- Breast Cancer
- Prostate Cancer
- Non-small Cell Lung Cancer
- Others
Companies covered
- Hengrui Medicine
- Sanofi
- Qilu Pharma
- Shenzhen Main Luck Pharma
- Jiangsu Aosaikang Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Docetaxel Market Size (2021-2032)
- 2.2.2 Global Docetaxel Sales (2021-2032)
- 2.2.3 Global Docetaxel Market Average Price (2021-2032)
- 2.3 Docetaxel by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 20 mg/ml
- 2.3.3 40 mg/ml
- 2.3.4 60 mg/ml
- 2.4 Docetaxel by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Breast Cancer
- 2.4.3 Prostate Cancer
- 2.4.4 Non-small Cell Lung Cancer
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Docetaxel Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Docetaxel Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Docetaxel Revenue of Manufacturers (2021-2026)
- 3.4 Global Docetaxel Average Price by Manufacturers (2021-2026)
- 3.5 Global Docetaxel Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Docetaxel, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Docetaxel, Product Type & Application
- 3.8 Global Manufacturers of Docetaxel, Established Date
- 3.9 Global Docetaxel Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Hengrui Medicine
- 4.1.1 Hengrui Medicine Company Information
- 4.1.2 Hengrui Medicine Business Overview
- 4.1.3 Hengrui Medicine Docetaxel Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Hengrui Medicine Docetaxel Product Portfolio
- 4.1.5 Hengrui Medicine Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Docetaxel Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Docetaxel Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Qilu Pharma
- 4.3.1 Qilu Pharma Company Information
- 4.3.2 Qilu Pharma Business Overview
- 4.3.3 Qilu Pharma Docetaxel Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Qilu Pharma Docetaxel Product Portfolio
- 4.3.5 Qilu Pharma Recent Developments
- 4.4 Shenzhen Main Luck Pharma
- 4.4.1 Shenzhen Main Luck Pharma Company Information
- 4.4.2 Shenzhen Main Luck Pharma Business Overview
- 4.4.3 Shenzhen Main Luck Pharma Docetaxel Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Shenzhen Main Luck Pharma Docetaxel Product Portfolio
- 4.4.5 Shenzhen Main Luck Pharma Recent Developments
- 4.5 Jiangsu Aosaikang Pharma
- 4.5.1 Jiangsu Aosaikang Pharma Company Information
- 4.5.2 Jiangsu Aosaikang Pharma Business Overview
- 4.5.3 Jiangsu Aosaikang Pharma Docetaxel Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Jiangsu Aosaikang Pharma Docetaxel Product Portfolio
- 4.5.5 Jiangsu Aosaikang Pharma Recent Developments
5 Global Docetaxel Market Scenario by Region
- 5.1 Global Docetaxel Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Docetaxel Sales by Region: 2021-2032
- 5.2.1 Global Docetaxel Sales by Region: 2021-2026
- 5.2.2 Global Docetaxel Sales by Region: 2027-2032
- 5.3 Global Docetaxel Revenue by Region: 2021-2032
- 5.3.1 Global Docetaxel Revenue by Region: 2021-2026
- 5.3.2 Global Docetaxel Revenue by Region: 2027-2032
- 5.4 North America Docetaxel Market Facts & Figures by Country
- 5.4.1 North America Docetaxel Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Docetaxel Sales by Country (2021-2032)
- 5.4.3 North America Docetaxel Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Docetaxel Market Facts & Figures by Country
- 5.5.1 Europe Docetaxel Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Docetaxel Sales by Country (2021-2032)
- 5.5.3 Europe Docetaxel Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Docetaxel Market Facts & Figures by Country
- 5.6.1 Asia Pacific Docetaxel Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Docetaxel Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Docetaxel Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Docetaxel Market Facts & Figures by Country
- 5.7.1 South America Docetaxel Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Docetaxel Sales by Country (2021-2032)
- 5.7.3 South America Docetaxel Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Docetaxel Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Docetaxel Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Docetaxel Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Docetaxel Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Docetaxel Sales by Type (2021-2032)
- 6.1.1 Global Docetaxel Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Docetaxel Sales Market Share by Type (2021-2032)
- 6.2 Global Docetaxel Revenue by Type (2021-2032)
- 6.2.1 Global Docetaxel Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Docetaxel Revenue Market Share by Type (2021-2032)
- 6.3 Global Docetaxel Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Docetaxel Sales by Application (2021-2032)
- 7.1.1 Global Docetaxel Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Docetaxel Sales Market Share by Application (2021-2032)
- 7.2 Global Docetaxel Revenue by Application (2021-2032)
- 7.2.1 Global Docetaxel Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Docetaxel Revenue Market Share by Application (2021-2032)
- 7.3 Global Docetaxel Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Docetaxel Value Chain Analysis
- 8.1.1 Docetaxel Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Docetaxel Production Mode & Process
- 8.2 Docetaxel Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Docetaxel Distributors
- 8.2.3 Docetaxel Customers
9 Global Docetaxel Analyzing Market Dynamics
- 9.1 Docetaxel Industry Trends
- 9.2 Docetaxel Industry Drivers
- 9.3 Docetaxel Industry Opportunities and Challenges
- 9.4 Docetaxel Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst